Related Experiment Video
Updated: May 15, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Serotypes associated with the development of pneumococcal para-pneumonic effusion in adults
Thomas Bewick1, Carmen Sheppard, Sonia Greenwood
1Dept of Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Insights
Certain pneumococcal serotypes (1, 3, 7F, 19A) commonly linked to childhood pneumonia complications are also significantly associated with adult para-pneumonic effusion (PPE). This finding highlights potential shifts in disease spectrum due to pneumococcal vaccination programs.
Area of Science:
- Infectious Diseases
- Pulmonology
- Vaccinology
Background:
- Childhood para-pneumonic effusion (PPE) is often caused by specific Streptococcus pneumoniae serotypes (1, 3, 7F, 19A).
- The association between pneumococcal serotypes and adult PPE remains less understood.
- Community-acquired pneumonia (CAP) is a significant cause of morbidity and mortality in adults.
Purpose of the Study:
- To investigate the specific pneumococcal serotypes associated with adult PPE.
- To compare serotype prevalence in adult PPE with that observed in childhood PPE.
- To assess the impact of pneumococcal conjugate vaccines (PCVs) on serotype distribution in adult PPE.
Main Methods:
- Prospective cohort study over 2 years.
- Inclusion of consecutive adult patients admitted with CAP.
- Pneumococcal serotyping from urine samples using multiplex immunoassay.
Main Results:
- Of 920 CAP patients, 100 had PPE; serotype determined in 73.
- Serotypes 1, 19A, and 3 were most frequently associated with adult PPE.
- Serotypes common in childhood PPE were independently associated with adult PPE (aOR 2.3).
- Non-PCV7 serotypes were more likely associated with PPE (OR 2.1).
Conclusions:
- Serotypes 1, 3, 7F, and 19A are independently associated with adult PPE, mirroring findings in childhood PPE.
- Serotype replacement following pneumococcal vaccine implementation may alter the clinical presentation of PPE.
- These findings have implications for vaccine strategies and clinical management of adult pneumonia.
Abstract:
Serotypes 1, 3, 7F and 19A are implicated in childhood pneumococcal para-pneumonic effusion (PPE). It is not known whether the same is true for adult PPE. A prospective cohort study was conducted over a 2-year period. Consecutive adults admitted with community-acquired pneumonia (CAP) were studied. Pneumococcal serotype was identified from urine samples using a multiplex immunoassay. Of 920 patients recruited, 366 had pneumococcal CAP; 100 of these had PPE and a serotype was determined in 73 patients. Factors associated with PPE were age, pneumonia severity index score and serotype. Serotypes most associated with PPE were 1 (18 (45%) out of 40), 19A (9 (45%) out of 20) and 3 (8 (40%) out of 20). Serotypes common in childhood PPE were independently associated with adult PPE (adjusted OR 2.3; p = 0.003). Serotypes not included in the 7-valent pneumococcal conjugate vaccine (PCV) were more likely to be associated with PPE (OR 2.1; p = 0.024) compared with those in the vaccine. Serotypes included in PCV-13 were as likely to be associated with PPE as those that are not (OR 0.8; p = 0.301). Serotypes 1, 3, 7F and 19A are independently associated with adult PPE, a similar finding to childhood PPE. Serotype replacement following pneumococcal vaccine implementation may influence the spectrum of clinical disease.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:

